All Stories

  1. Cryptococcus gattii Infections
  2. Vulnerability, hysteria and fear — conquering Ebola virus
  3. The Genus Scedosporium and Pseudallescheria: Current Challenges in Laboratory Diagnosis
  4. Functional disruption of yeast metacaspase, Mca1, leads to miltefosine resistance and inability to mediate miltefosine-induced apoptotic effects
  5. Cryptococcus neoformans: Latency and Disease
  6. Signaling Cascades and Enzymes as Cryptococcus Virulence Factors
  7. Clinical Perspectives on Cryptococcus neoformans and Cryptococcus gattii: Implications for Diagnosis and Management
  8. Functional characterization of the hexose transporter Hxt13p: An efflux pump that mediates resistance to miltefosine in yeast
  9. Cryptococcus gattiiinfections: contemporary aspects of epidemiology, clinical manifestations and management of infection
  10. Faculty Opinions recommendation of Combination antifungal therapy for cryptococcal meningitis.
  11. Practical identification of eight medically important Trichosporon species by reverse line blot hybridization (RLB) assay and rolling circle amplification (RCA)
  12. Human rhinovirus C in adult haematopoietic stem cell transplant recipients with respiratory illness
  13. The Crz1/Sp1 Transcription Factor of Cryptococcus neoformans Is Activated by Calcineurin and Regulates Cell Wall Integrity
  14. Clinical Utility of the Cryptococcal Antigen Lateral Flow Assay in a Diagnostic Mycology Laboratory
  15. Multiplex-Tandem PCR for Fungal Diagnostics
  16. One world, one health: beyond the Millennium Development Goals
  17. Faculty Opinions recommendation of Utilization of omeprazole to augment subtherapeutic voriconazole concentrations for treatment of Aspergillus infections.
  18. Faculty Opinions recommendation of Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: an assessment of currently available triazoles.
  19. Pneumonia and Lung Infections due to Emerging and Unusual Fungal Pathogens
  20. Doing the right thing for tuberculosis control in the Torres Strait Islands
  21. Faculty Opinions recommendation of Ocular manifestations of candidemia.
  22. - Rhinocladiella
  23. Faculty Opinions recommendation of Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients.
  24. Rapid Etiological Classification of Meningitis by NMR Spectroscopy Based on Metabolite Profiles and Host Response
  25. SEC14 is a specific requirement for secretion of phospholipase B1 and pathogenicity of Cryptococcus neoformans
  26. Design issues in a randomized controlled trial of a pre-emptive versus empiric antifungal strategy for invasive aspergillosis in patients with high-risk hematologic malignancies
  27. Nocardia Infections of the Face and Neck
  28. Faculty Opinions recommendation of 1,25-dihydroxyvitamin D3 modulates cytokine production induced by Candida albicans: impact of seasonal variation of immune responses.
  29. Cryptococcus gattii Virulence Composite: Candidate Genes Revealed by Microarray Analysis of High and Less Virulent Vancouver Island Outbreak Strains
  30. Echinocandin Antifungal Drugs in Fungal Infections
  31. Improved identification of Gordonia, Rhodococcus and Tsukamurella species by 5'-end 16S rRNA gene sequencing
  32. Recent advances in management of cryptococcal meningitis: commentary
  33. Clinical associations and prevalence of Scedosporium spp. in Australian cystic fibrosis patients: identification of novel risk factors?
  34. Prophylaxis, empirical and preemptive treatment of invasive candidiasis
  35. Antifungal therapy in invasive fungal infections
  36. Management of Invasive Candidiasis in the Intensive Care Unit
  37. Faculty Opinions recommendation of The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis.
  38. Nocardia Species
  39. Faculty Opinions recommendation of Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis.
  40. Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing
  41. Faculty Opinions recommendation of Dexamethasone in Cryptococcus gattii central nervous system infection.
  42. Rapid Etiological Classification of Meningitis by NMR Spectroscopy Based on Metabolite Profiles and Host Response
  43. Faculty Opinions recommendation of Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.
  44. Fungal-Derived Immune Modulating Molecules
  45. Determinants of mortality in non-neutropenic ICU patients with candidaemia
  46. Faculty Opinions recommendation of Association of fluconazole pharmacodynamics with mortality in patients with candidemia.
  47. The role of nuclear magnetic resonance in medical mycology
  48. Role and mechanism of phosphatidylinositol‐specific phospholipase C in survival and virulence of Cryptococcus neoformans
  49. Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp.
  50. Faculty Opinions recommendation of High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial.
  51. Faculty Opinions recommendation of Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial.
  52. Association between fertility and molecular sub-type of global isolates ofCryptococcus gattiimolecular type VGII
  53. Optimizing Therapy for Candida Infections
  54. Synthesis, antifungal and antimicrobial activity of alkylphospholipids
  55. Detection of Fungal Metabolites
  56. Synthesis, antifungal and haemolytic activity of a series of bis(pyridinium)alkanes
  57. Cryptococcal phospholipase B antigen is not detected in serum of patients infected with Cryptococcus neoformans using a sandwich enzyme-linked immunosorbent assay
  58. Active Surveillance of Candidemia, Australia
  59. N-linked glycosylation sites affect secretion of cryptococcal phospholipase B1, irrespective of glycosylphosphatidylinositol anchoring
  60. Application of proton nuclear magnetic resonance spectroscopy to the study ofCryptococcusand cryptococcosis
  61. Phospholipase B activity enhances adhesion of Cryptococcus neoformans to a human lung epithelial cell line
  62. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients
  63. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia
  64. A rapid screening test to distinguish betweenCandida albicansandCandida dubliniensisusing NMR spectroscopy
  65. Secretion of cryptococcal phospholipase B1 (PLB1) is regulated by a glycosylphosphatidylinositol (GPI) anchor
  66. Cryptococcal phospholipases: a novel lysophospholipase discovered in the pathogenic fungus Cryptococcus gattii
  67. Antifungal agents for preventing fungal infections in solid organ transplant recipients
  68. Cloning of CnLYSO1, a novel extracellular lysophospholipase of the pathogenic fungus Cryptococcus neoformans
  69. Isolation and characterisation of the phospholipase B gene of Cryptococcus neoformans var. gattii
  70. Metabolites released by Cryptococcus neoformans var. neoformans and var. gattii differentially affect human neutrophil function
  71. Strain-dependent effects of environmental signals on the production of extracellular phospholipase by Cryptococcus neoformans
  72. Cryptococcomas Distinguished from Gliomas with MR Spectroscopy: An Experimental Rat and Cell Culture Study
  73. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans
  74. Purification and characterization of secretory phospholipase B, lysophospholipase and lysophospholipase/transacylase from a virulent strain of the pathogenic fungus Cryptococcus neoformans
  75. Heteronuclear NMR studies of metabolites produced by Cryptococcus neoformans in culture media: Identification of possible virulence factors
  76. Heteronuclear NMR studies of metabolites produced byCryptococcus neoformans in culture media: Identification of possible virulence factors
  77. Oxidative Stress and the Mobilisation of Arachidonic Acid in Stimulated Human Platelets: Role of Hydroxyl Radical
  78. Identification of pathogenic yeasts of the imperfect genus Candida by polymerase chain reaction fingerprinting
  79. Using Australian cryptococcal surveillance data to improve AIDS surveillance in NSW
  80. Inhibition of the human platelet cyclooxygenase response by the naturally occurring phenazine derivative, 1-hydroxyphenazine
  81. Inhibition of Platelet Eicosanoid Metabolism by the Bacterial Phenazine Derivative Pyocyanin
  82. 3 Human immunodeficiency virus infection in pregnancy
  83. Public health response to a suspected case of Lassa fever
  84. A comparison of hospital and community-acquired infective endocarditis
  85. GMP-140 (P-selectin) inhibits human neutrophil activation by lipopolysaccharide: Analysis by proton magnetic resonance spectroscopy
  86. Comparison of human polymorphonuclear leukocytes from peripheral blood and purulent exudates by high resolution 1H MRS
  87. EXTRAPULMONARY TUBERCULOSIS A CONTINUING PROBLEM IN AUSTRALIA
  88. A prospective study of adverse reactions associated with vancomycin therapy
  89. Quantitation of sulfidopeptide leukotrienes by reversed-phase high-performance liquid chromatography
  90. Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus
  91. Phenytoin Sensitivity in a Case of Phenytoin‐Associated Hodgkin's Disease*
  92. Complexity of Magnetic Resonance Spectrum Classification